Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis

Maarten E Witte, Don J Mahad, Hans Lassmann, Jack van Horssen

Research output: Contribution to journalLiterature reviewpeer-review

Abstract / Description of output

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. Current treatments are very effective in reducing the neuroinflammatory attack, but fail to significantly halt disease progression and associated loss of neuronal tissue. In recent years, it has become increasingly clear that dysfunctional mitochondria are important contributors to damage and loss of both axons and neurons. Observations in animal and histopathological studies suggest that infiltrating leukocytes and activated microglia play a central role in neuronal mitochondrial dysfunction. This review provides a comprehensive overview on the current knowledge regarding mitochondrial dysfunction in MS. Importantly, more insight into the cause and consequences of impaired mitochondrial function provide a basis for mitochondrial-targeted medicine to combat progressive MS.

Original languageEnglish
Pages (from-to)179-87
Number of pages9
JournalTrends in Molecular Medicine
Issue number3
Publication statusPublished - Mar 2014

Keywords / Materials (for Non-textual outputs)

  • Animals
  • Axons
  • Demyelinating Diseases
  • Disease Models, Animal
  • Disease Progression
  • Humans
  • Mitochondria
  • Multiple Sclerosis
  • Neurons


Dive into the research topics of 'Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis'. Together they form a unique fingerprint.

Cite this